TRANSACTIONS
Récentes Transactions
2024 : AdScientiam secures an undisclosed financing to fuel its growth
2024: Primaa secures pre-series A financing
2024: InHeart secures 10m€ series A financing
2023: Novadip secures 18M€ venture loan financing with EIB
2023: Avatar Medical secures 5M€ seed financing
2022 : TechnoConcept secures 4.4M€ financing and secondary buy-out
2022 : Harmony Biosciences acquires Bioprojet’s Wakix XR US licensing rights
2021 : Novadip 21M€ series B1 financing
2021 : Robocath secures 15M€ financing with EIB
2020 : Robocath 40M€ series C financing
2020 : European Licensing-out Advisory for Catabasis Pharmaceuticals
2019 : Beaver Visitec acquires Arcadophta
2019 : FineHeart 5M€ bridge financing
Bionest Partners Finance a réalisé un grand nombre de projets de conseil financier pour des startups Healthtech et des sociétés pharmaceutiques spécialisées (fairness opinion, business plan, deal structuration).